264 related articles for article (PubMed ID: 30710016)
21. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo.
Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
Cancer Res; 2004 Oct; 64(20):7210-5. PubMed ID: 15492235
[TBL] [Abstract][Full Text] [Related]
22. Defining the Conformational Ensembles Associated with Ligand Binding to Cyclooxygenase-2.
Dong L; Malkowski MG
Biochemistry; 2023 Nov; 62(21):3134-3144. PubMed ID: 37852627
[TBL] [Abstract][Full Text] [Related]
23. Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.
Goodman MC; Xu S; Rouzer CA; Banerjee S; Ghebreselasie K; Migliore M; Piomelli D; Marnett LJ
J Biol Chem; 2018 Mar; 293(9):3028-3038. PubMed ID: 29326169
[TBL] [Abstract][Full Text] [Related]
24. [Management of Adverse Effects Associated with Nonsteroidal Anti-inflammatory Drugs and COX-2 Inhibitor].
Masuda R
Masui; 2016 Aug; 65(7):709-717. PubMed ID: 30358302
[TBL] [Abstract][Full Text] [Related]
25. Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1.
Akasaka H; Ruan KH
Arch Biochem Biophys; 2016 Aug; 603():29-37. PubMed ID: 27177970
[TBL] [Abstract][Full Text] [Related]
26. Druggable Prostanoid Pathway.
Mazaleuskaya LL; Ricciotti E
Adv Exp Med Biol; 2020; 1274():29-54. PubMed ID: 32894506
[TBL] [Abstract][Full Text] [Related]
27. The Coxib case: Are EP receptors really guilty?
Santilli F; Boccatonda A; Davì G; Cipollone F
Atherosclerosis; 2016 Jun; 249():164-73. PubMed ID: 27105159
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 inhibitors in tumorigenesis (part I).
Taketo MM
J Natl Cancer Inst; 1998 Oct; 90(20):1529-36. PubMed ID: 9790545
[TBL] [Abstract][Full Text] [Related]
29. Cyclo-oxygenase isoenzymes: physiological and pharmacological role.
Kam PC; See AU
Anaesthesia; 2000 May; 55(5):442-9. PubMed ID: 10792135
[TBL] [Abstract][Full Text] [Related]
30. The pathophysiologic role of cyclo-oxygenases in the eye.
Radi ZA; Render JA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):141-51. PubMed ID: 18355129
[TBL] [Abstract][Full Text] [Related]
31. Molecular dynamics simulations of arachidonic acid complexes with COX-1 and COX-2: insights into equilibrium behavior.
Furse KE; Pratt DA; Porter NA; Lybrand TP
Biochemistry; 2006 Mar; 45(10):3189-205. PubMed ID: 16519514
[TBL] [Abstract][Full Text] [Related]
32. The structures of prostaglandin endoperoxide H synthases-1 and -2.
Garavito RM; Malkowski MG; DeWitt DL
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():129-52. PubMed ID: 12432914
[TBL] [Abstract][Full Text] [Related]
33. Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.
Botting RM
Pharmacol Rep; 2010; 62(3):518-25. PubMed ID: 20631416
[TBL] [Abstract][Full Text] [Related]
34. Molecular Mechanisms in the Selectivity of Nonsteroidal Anti-Inflammatory Drugs.
Shamsudin Y; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2018 Feb; 57(7):1236-1248. PubMed ID: 29345921
[TBL] [Abstract][Full Text] [Related]
35. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
Rao P; Knaus EE
J Pharm Pharm Sci; 2008 Sep; 11(2):81s-110s. PubMed ID: 19203472
[TBL] [Abstract][Full Text] [Related]
36. COXIBs, CINODs and H₂S-releasing NSAIDs: current perspectives in the development of safer non steroidal anti-inflammatory drugs.
Fiorucci S; Distrutti E
Curr Med Chem; 2011; 18(23):3494-505. PubMed ID: 21756233
[TBL] [Abstract][Full Text] [Related]
37. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
[TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
Howard PA; Delafontaine P
J Am Coll Cardiol; 2004 Feb; 43(4):519-25. PubMed ID: 14975457
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
40. Anti-inflammatory drugs, cyclooxygenases and other factors.
Bennett A
Expert Opin Pharmacother; 2001 Jan; 2(1):1-2. PubMed ID: 11336563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
